Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 6 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 16 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0005930 | axoneme | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
GO:0005929 | cilium | 4 | 9 |
GO:0042995 | cell projection | 2 | 9 |
GO:0043226 | organelle | 2 | 9 |
GO:0043227 | membrane-bounded organelle | 3 | 9 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 9 |
Related structures:
AlphaFold database: Q4QAN0
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 191 | 195 | PF00656 | 0.442 |
CLV_NRD_NRD_1 | 100 | 102 | PF00675 | 0.250 |
CLV_NRD_NRD_1 | 21 | 23 | PF00675 | 0.463 |
CLV_PCSK_KEX2_1 | 20 | 22 | PF00082 | 0.475 |
CLV_PCSK_KEX2_1 | 208 | 210 | PF00082 | 0.553 |
CLV_PCSK_SKI1_1 | 44 | 48 | PF00082 | 0.418 |
CLV_PCSK_SKI1_1 | 85 | 89 | PF00082 | 0.250 |
DEG_APCC_DBOX_1 | 19 | 27 | PF00400 | 0.579 |
DOC_CDC14_PxL_1 | 184 | 192 | PF14671 | 0.450 |
DOC_MAPK_gen_1 | 101 | 108 | PF00069 | 0.450 |
DOC_MAPK_gen_1 | 189 | 198 | PF00069 | 0.450 |
DOC_MAPK_gen_1 | 85 | 95 | PF00069 | 0.450 |
DOC_MAPK_MEF2A_6 | 65 | 72 | PF00069 | 0.493 |
DOC_PP2B_LxvP_1 | 106 | 109 | PF13499 | 0.450 |
DOC_PP4_MxPP_1 | 50 | 53 | PF00568 | 0.440 |
DOC_USP7_MATH_1 | 168 | 172 | PF00917 | 0.519 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.486 |
LIG_eIF4E_1 | 137 | 143 | PF01652 | 0.464 |
LIG_FHA_1 | 72 | 78 | PF00498 | 0.471 |
LIG_FHA_2 | 123 | 129 | PF00498 | 0.464 |
LIG_FHA_2 | 145 | 151 | PF00498 | 0.450 |
LIG_FHA_2 | 189 | 195 | PF00498 | 0.442 |
LIG_FHA_2 | 53 | 59 | PF00498 | 0.465 |
LIG_FHA_2 | 61 | 67 | PF00498 | 0.523 |
LIG_LIR_Gen_1 | 117 | 124 | PF02991 | 0.450 |
LIG_LIR_Gen_1 | 145 | 153 | PF02991 | 0.539 |
LIG_LIR_Gen_1 | 178 | 188 | PF02991 | 0.464 |
LIG_LIR_Nem_3 | 112 | 118 | PF02991 | 0.457 |
LIG_LIR_Nem_3 | 145 | 149 | PF02991 | 0.539 |
LIG_LIR_Nem_3 | 178 | 184 | PF02991 | 0.464 |
LIG_LRP6_Inhibitor_1 | 95 | 101 | PF00058 | 0.250 |
LIG_MAD2 | 44 | 52 | PF02301 | 0.424 |
LIG_MYND_3 | 108 | 112 | PF01753 | 0.505 |
LIG_NRP_CendR_1 | 208 | 210 | PF00754 | 0.553 |
LIG_SH2_CRK | 181 | 185 | PF00017 | 0.464 |
LIG_SH2_NCK_1 | 118 | 122 | PF00017 | 0.450 |
LIG_SH3_3 | 194 | 200 | PF00018 | 0.464 |
LIG_SUMO_SIM_anti_2 | 158 | 164 | PF11976 | 0.476 |
LIG_TRAF2_1 | 175 | 178 | PF00917 | 0.481 |
LIG_TRAF2_1 | 29 | 32 | PF00917 | 0.536 |
LIG_TRAF2_1 | 39 | 42 | PF00917 | 0.404 |
LIG_UBA3_1 | 183 | 189 | PF00899 | 0.464 |
LIG_UBA3_1 | 47 | 56 | PF00899 | 0.409 |
MOD_CK1_1 | 172 | 178 | PF00069 | 0.539 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.569 |
MOD_CK2_1 | 142 | 148 | PF00069 | 0.451 |
MOD_CK2_1 | 172 | 178 | PF00069 | 0.464 |
MOD_CK2_1 | 3 | 9 | PF00069 | 0.431 |
MOD_CK2_1 | 60 | 66 | PF00069 | 0.535 |
MOD_GlcNHglycan | 171 | 174 | PF01048 | 0.345 |
MOD_GSK3_1 | 168 | 175 | PF00069 | 0.519 |
MOD_N-GLC_2 | 154 | 156 | PF02516 | 0.250 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.534 |
MOD_NEK2_1 | 114 | 119 | PF00069 | 0.450 |
MOD_NEK2_1 | 136 | 141 | PF00069 | 0.450 |
MOD_NEK2_1 | 142 | 147 | PF00069 | 0.450 |
MOD_NEK2_1 | 169 | 174 | PF00069 | 0.537 |
MOD_NEK2_1 | 30 | 35 | PF00069 | 0.559 |
MOD_NEK2_1 | 70 | 75 | PF00069 | 0.452 |
MOD_Plk_1 | 59 | 65 | PF00069 | 0.487 |
MOD_Plk_2-3 | 60 | 66 | PF00069 | 0.535 |
MOD_SUMO_for_1 | 109 | 112 | PF00179 | 0.488 |
TRG_DiLeu_BaEn_1 | 42 | 47 | PF01217 | 0.389 |
TRG_ENDOCYTIC_2 | 118 | 121 | PF00928 | 0.455 |
TRG_ENDOCYTIC_2 | 179 | 182 | PF00928 | 0.450 |
TRG_ER_diArg_1 | 19 | 22 | PF00400 | 0.486 |
TRG_ER_diArg_1 | 208 | 210 | PF00400 | 0.553 |
TRG_Pf-PMV_PEXEL_1 | 101 | 105 | PF00026 | 0.250 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A096MJZ0 | Rattus norvegicus | 42% | 100% |
A0A0N1PBU3 | Leptomonas seymouri | 89% | 100% |
A0A0S4JQV7 | Bodo saltans | 70% | 99% |
A0A1X0NVY4 | Trypanosomatidae | 78% | 100% |
A0A3Q8IC25 | Leishmania donovani | 99% | 100% |
A0A3R7LR73 | Trypanosoma rangeli | 78% | 100% |
A4HDF9 | Leishmania braziliensis | 93% | 100% |
A4I0U0 | Leishmania infantum | 99% | 100% |
D0A771 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 74% | 100% |
D0A8W7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 27% | 73% |
E9ATS2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 31% | 67% |
E9AWU4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 98% | 100% |
Q05A62 | Mus musculus | 43% | 100% |
Q28G94 | Xenopus tropicalis | 43% | 100% |
Q2KID4 | Bos taurus | 43% | 100% |
Q4LDG9 | Homo sapiens | 43% | 100% |
Q641R9 | Xenopus laevis | 43% | 100% |
Q6DHB1 | Danio rerio | 44% | 100% |
Q8T888 | Ciona intestinalis | 43% | 100% |
Q9XHH2 | Chlamydomonas reinhardtii | 48% | 100% |